INTELLIGENT BIO SOLUTIONS INC. INBS revenue by segment, product and geography
In its fiscal year ending 2026-06-30, INTELLIGENT BIO SOLUTIONS INC. reported revenue across 3 products and services; the largest, Sales Of Goods Cartidges, was $2.49M, 59.0% of the filed sum (+41.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Sales Of Goods Cartidges$2.49M59.0%+41.1% yoy
- Sales Of Goods Readers$902K21.4%+26.8% yoy
- Other Sales Accessories$827K19.6%+43.0% yoy
Members sum to the consolidated $4.22M for this period.
- United Kingdom$4.15M98.5%+44.8% yoy
- Other Country$40.2K1.0%-69.7% yoy
- Asia Pacific$12.5K0.3%-57.3% yoy
- Americas$8.75K0.2%-61.3% yoy
Members sum to the consolidated $4.22M for this period.
- Sales Of Goods Cartidges$704K66.3%+59.2% yoy
- Other Sales Accessories$218K20.5%+80.0% yoy
- Sales Of Goods Readers$139K13.1%-15.9% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.